8-K
Current Report
Vistagen Therapeutics, Inc. Filed Acc 0001851734-22-000643
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading vtgn20221028_8k.htm…